Phase 2 Trial of First-Line Therapy With Satraplatin and Paclitaxel in Patients With Unresectable Stage III or IV Non-Small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2012
At a glance
- Drugs Paclitaxel; Satraplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors GPC Biotech Inc
- 27 Apr 2012 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2008 Status change
- 03 Jun 2008 Final results presented at ASCO 2008.